New Insights into the Pathophysiology and Treatment of Non-Cystic Fibrosis Bronchiectasis

Activity Overview

Panel Discussion 

This 30-minute interactive panel discussion with an interprofessional clinical expert panel and an experienced patient with non-cystic fibrosis bronchiectasis (NCFBE) will focus on disease burden, symptom recognition, diagnosis, immunopathology, and emerging therapies for patients with NCFBE.

Link to Module 1

Link to Module 2

0.50 CE Credit(s)
Expires: December 14, 2023

Target Audience

Pulmonology, infectious diseases, primary care, and radiology clinicians managing patients with NCFBE

Learning Objectives

Upon successful completion of this educational activity, participants should be better able to:

  • Identify the impact of non-cystic fibrosis bronchiectasis (NCFBE) and its exacerbations on patient quality of life
  • Utilize clinical practice guidelines for NCFBE diagnosis
  • Examine emerging treatments targeting the underlying immune-mediated pathophysiologic processes of NCFBE
  • Integrate the unique roles and responsibilities of the interprofessional care team when diagnosing and treating patients with NCFBE

Activity Faculty

196-22-847-VL-002-Dr._Metersky-Faculty_Headshot-300x365_1669981255797

Mark L. Metersky, MD, FCCP

Margaret M. Johnson, MD

Margaret M. Johnson, MD

Professor, Medicine
Mayo Clinic College of Medicine and Science
Consultant, Pulmonary Medicine
Mayo Clinic
Jacksonville, FL

Molly Mailes, MSN, RN, MEDSURG-BC

Molly Mailes, MSN, RN, MEDSURG-BC

Nurse Program Coordinator, Adult Cystic Fibrosis
Mayo Clinic
Jacksonville, FL

Provider Statement

This activity is provided by RMEI Medical Education, LLC

Supporter Statement

This activity is supported by an educational grant from Insmed

Subscribe

Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources